Evidence map›Paper›PMID 32284576›Full record

ArticleNature chemistry2020

Total synthesis of brevianamide A.

Robert C Godfrey, Nicholas J Green, Gary S Nichol, Andrew L Lawrence

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. The Diels-Alder Reaction as a Key Step in Natural Product Synthesis.Progress in the chemistry of organic natural products · 2026
    Review
  3. Article
  4. Decoding theJournal of agricultural and food chemistry · 2025
    Article
  5. Article
  6. Total Synthesis of Brevianamide S.Organic letters · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. New Trends and Future Opportunities in the Enzymatic Formation of C-C, C-N, and C-O bonds.Chembiochem : a European journal of chemical biology · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Robert C GodfreyEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.
Nicholas J GreenEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-3874-7359
Gary S NicholEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.
Andrew L LawrenceEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK. a.lawrence@ed.ac.uk.ORCID http://orcid.org/0000-0002-9573-5637
University of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fungal-derived bicyclo[2.2.2]diazaoctane alkaloids are of interest to the scientific community for their potent and varied biological activities. Within this large and diverse family of natural products, the insecticidal metabolite (+)-brevianamide A is particularly noteworthy for its synthetic intractability and inexplicable biogenesis. Despite five decades of research, this alkaloid has remained an elusive target for chemical synthesis due to insurmountable issues of reactivity and selectivity associated with all previously explored strategies. We herein report the chemical synthesis of (+)-brevianamide A (seven steps, 7.2% overall yield, 750 mg scale), which involves a bioinspired cascade transformation of the linearly fused (-)-dehydrobrevianamide E into the topologically complex bridged-spiro-fused structure of (+)-brevianamide A.

Indexed as

AlkaloidsBiological ProductsChemistry Techniques, SyntheticCyclizationMolecular StructurePenicilliumPiperazinesSpiro CompoundsStereoisomerismAlkaloidsBiological Productsbrevianamide APiperazinesSpiro Compounds

Identifiers

PMID32284576
OpenAlexW3015624775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.